Form 13-F position report

APOLLO MEDICAL HLDGS INC

Reported by NORTHERN TRUST CORPORATION

AMEH CUSIP 03763A207 Manager CIK 0000073124

Reported 452,732 shares, down 14,774 (3.2%) from the prior quarter.

Reported value 20.2%; share count -3.2% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q4 2023
Shares 452,732 Quarter-end amount reported
Reported value $17,339,635 Fair value at quarter end
Consecutive quarters held 23 Through Q4 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 38757000
2021-12-31 31003000
2022-03-31 19643000
2022-06-30 15737000
2022-09-30 16021000
2022-12-31 12513434
2023-03-31 15774077
2023-06-30 14637783
2023-09-30 14422561
2023-12-31 17339635
2024-03-31 18786074
2024-06-30 17294217
2024-09-30 24575078
2024-12-31 14730154
2025-03-31 14289469
2025-06-30 10809563
2025-09-30 11999108
2025-12-31 9985107
2026-03-31 10743758
2026-06-30 23439092

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for APOLLO MEDICAL HLDGS INC held by NORTHERN TRUST CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Added 505,044 +66,881 (15.3%) < 0.01% $23,439,092 2026-08-13
Q1 2026 Added 438,163 +35,700 (8.9%) < 0.01% $10,743,758 2026-05-14
Q4 2025 Reduced 402,463 -20,786 (-4.9%) < 0.01% $9,985,107 2026-02-17
Q3 2025 Reduced 423,249 -11,219 (-2.6%) < 0.01% $11,999,108 2025-11-14
Q2 2025 Reduced 434,468 -26,334 (-5.7%) < 0.01% $10,809,563 2025-08-13
Q1 2025 Reduced 460,802 -6,377 (-1.4%) < 0.01% $14,289,469 2025-05-13
Q4 2024 Added 467,179 +43,032 (10.1%) < 0.01% $14,730,154 2025-02-14
Q3 2024 Reduced 424,147 -2,239 (-0.5%) < 0.01% $24,575,078 2024-11-13
Q2 2024 Reduced 426,386 -21,008 (-4.7%) < 0.01% $17,294,217 2024-08-14
Q1 2024 Reduced 447,394 -5,338 (-1.2%) < 0.01% $18,786,074 2024-05-14
Q4 2023 Reduced 452,732 -14,774 (-3.2%) < 0.01% $17,339,635 2024-02-13
Q3 2023 Added 467,506 +4,285 (0.9%) < 0.01% $14,422,561 2023-11-13
Q2 2023 Added 463,221 +30,699 (7.1%) < 0.01% $14,637,783 2023-08-11
Q1 2023 Added 432,522 +9,628 (2.3%) < 0.01% $15,774,077 2023-05-15
Q4 2022 Added 422,894 +12,104 (2.9%) < 0.01% $12,513,434 2023-02-13
Q3 2022 Added 410,790 +2,974 (0.7%) < 0.01% $16,021,000 2022-11-14
Q2 2022 Added 407,816 +2,565 (0.6%) < 0.01% $15,737,000 2022-08-12
Q1 2022 Reduced 405,251 -16,675 (-4.0%) < 0.01% $19,643,000 2022-05-13
Q4 2021 Reduced 421,926 -3,741 (-0.9%) < 0.01% $31,003,000 2022-02-08
Q3 2021 Added 425,667 +54,979 (14.8%) < 0.01% $38,757,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

156 managers reported APOLLO MEDICAL HLDGS INC for Q4 2023.

Managers reporting APOLLO MEDICAL HLDGS INC in Q4 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 6,498,075 -30,420 < 0.01% $248,876,273 23 qtrs
VANGUARD GROUP INC Added 5,049,928 +260,687 < 0.01% $193,412,242 23 qtrs
STATE STREET CORPORATION Reduced 1,546,620 -50,407 < 0.01% $59,235,546 23 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 944,449 +42,278 < 0.01% $36,176,355 23 qtrs
DIMENSIONAL FUND ADVISORS LP Added 768,520 +59,895 < 0.01% $29,437,651 22 qtrs
Steel Peak Wealth Management LLC Added 677,176 +65,000 1.5% $25,935,841 9 qtrs
325 CAPITAL LLC Unchanged 592,810 0 11.25% $22,704,623 6 qtrs
NORTHERN TRUST CORPORATION This report Reduced 452,732 -14,774 < 0.01% $17,339,635 23 qtrs
MORGAN STANLEY Added 391,199 +111,202 < 0.01% $14,982,922 25 qtrs
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Added 344,029 +13,526 < 0.01% $13,176,311 23 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2023
Filed
February 13, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
14,844
Shared
437,888
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.